Latest Articles
Patient-Derived Endometrium Chip Aims to Personalize Infertility Treatment - 동아사이언스
Patient-Derived Endometrium Chip Aims to Personalize Infertility Treatment 동아사이언스
Published: Jan. 6, 2026, 8:26 a.m.
I spent £10,000 to treat my endometriosis – we don’t need more NHS hurdles - The i Paper
I spent £10,000 to treat my endometriosis – we don’t need more NHS hurdles The i Paper
Published: Jan. 6, 2026, 6 a.m.
The common conditions the new NHS ‘online hospital’ will treat - The Independent
The common conditions the new NHS ‘online hospital’ will treat The Independent
Published: Jan. 6, 2026, 12:30 a.m.
From contraception to menopause and IVF: How $25 scripts will reshape women’s health - Women's Agenda
From contraception to menopause and IVF: How $25 scripts will reshape women’s health Women's Agenda
Published: Jan. 6, 2026, 12:16 a.m.
Nine common conditions to be managed via new NHS online hospital - The Independent
Nine common conditions to be managed via new NHS online hospital The Independent
Published: Jan. 5, 2026, 10:30 p.m.
Patients to access specialists via NHS online hospitals - see list of conditions - The Mirror
Patients to access specialists via NHS online hospitals - see list of conditions The Mirror
Published: Jan. 5, 2026, 10:30 p.m.
Neuroscience drugmaker CEO to speak at J.P. Morgan healthcare event - Stock Titan
Neuroscience drugmaker CEO to speak at J.P. Morgan healthcare event Stock Titan
Published: Jan. 5, 2026, 9:01 p.m.
Petition against introduction of digital ID cards most signed in Hemel Hempstead constituency - Hemel Today
Petition against introduction of digital ID cards most signed in Hemel Hempstead constituency Hemel Today
Published: Jan. 5, 2026, 3:43 p.m.
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology
Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Jan. 5, 2026, 1:12 p.m.
Link copied to clipboard!